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Abstract  
We describe what we believe is an entirely novel case of a 15-year-old boy with idiopathic 
acute eosinophilic pneumonia and unusual, resistant hypoxaemia which necessitated 
extracorporeal membrane oxygenation. Response to corticosteroids was excellent and a full 
recovery was observed. Smoking cigarettes and cannabis on the day the symptoms began may 
have contributed to the occurrence of this rare disease.  
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Introduction  
Acute eosinophilic pneumonia (AEP) is a rare entity with an incidence of 9.1 per 100,000 
person-years which typically affects young men around the age of 30 years.1 We report here 
an extraordinary case of idiopathic AEP in the sense that the patient was young (15 years) and 
the disease extremely severe, requiring mechanical ventilation and extracorporeal membrane 
oxygenation (ECMO) and possibly precipitated or exacerbated by smoking tobacco and 
cannabis. 
Case Report  
A teenaged boy aged 15 was admitted to our paediatric intensive care unit with acute 
respiratory distress syndrome and resistant hypoxaemia requiring ECMO. He had a history of 
atopy and mild asthma which had resolved symptomatically by the time he was 7 years old. 
He was exposed to environmental tobacco smoke regularly at home and for the past few 
months had begun smoking cigarettes occasionally himself. He also reported smoking 
cannabis for the first time about 3 months prior to admission and on a second occasion just a 
few hours before the onset of his current respiratory symptoms. He was in contact at home 
with budgerigars and a dog, and had been working for the past 5 months as a garage 
mechanic. 
24 hours before his admission he had woken up with a fever (38.4°C) accompanied by 
asthenia and odynophagia but no respiratory symptoms. He took some paracetamol. Later on 
in the afternoon, according to his family he smoked cannabis for the second time in 3 months. 
As the evening and night progressed he developed rapidly deteriorating respiratory distress, 
chest tightness and orthopnoea which led him to visit the emergency ward of a nearby 
hospital. On arrival he was noted to be febrile, anxious and hypoxic (pulse oximetry 85% 
saturation on room air). Despite nasal oxygen therapy and ad hoc antibiotic therapy with 
cefotaxime he failed to improve and remained significantly hypoxaemic (pulse oximetry 
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90%) even when administered 20l of oxygen by face mask. He was therefore transferred to 
the intensive care unit. Arterial blood gases showed pH 7.34, PaO2 117 mmHg, PaCO2 42 
mmHg. A chest X-ray showed bilateral alveolar and interstitial infiltrates (Figure 1). Because 
of the progression of the respiratory distress and the appearance of haemodynamic instability, 
he was intubated and commenced on ventilatory support with PaO2/FiO2 ratio 77 mmHg and 
PEEP at 10 cmH2O. Noradrenaline was commenced and anti-infectious therapy widened with 
cefotaxime, levofloxacin, trimethoprim-sulphamethoxazole and amphotericin B. 
Meanwhile other extensive tests were performed. The white cell count was 22 x 109/L with 
0.2 x 109/L eosinophils, C-reactive protein 221 mg/L and procalcitonin 0.87 ng/ml. The 
procalcitonin control was 1.35 ng/ml. The brain natriuretic peptide was 44 pg/ml. 
Nasopharyngeal aspiration did not reveal RSV or A and B influenza viruses. Serology 
(influenza A, B, HIV, Mycoplasma, Chlamydia and Legionella) eventually proved negative. 
Blood cultures remained sterile. Urinary Legionella pneumophila and Streptococcus 
pneumoniae antigens were negative. Complement and immunoglobulin assays were normal. 
There were no signs of immune dysregulation (normal lymphocyte typing, negative 
antinuclear and anticytoplasmic antibodies, negative anti-MPO and anti-PR3 ANA and no 
paraprotein). A CT scan of the thorax confirmed mixed reticular and alveolar bilateral 
pulmonary infiltrates concentrated sub-pleurally with ground-glass opacification and pleural 
effusions consistent with an acute eosinophilic pneumonia (Figure 2). Bronchoalveolar lavage 
returned pinkish fluid with 350 000 cells/mm3 (38% eosinophils, 28% macrophages, 16% 
lymphocytes, 18% neutrophils). There was no evidence of parasitic, fungal, bacterial or viral 
infection. 
The patient developed a refractory hypoxaemia (pH 7.38, PaO2 69.1 mmHg, PaCO2 46.7 
mmHg, HCO3- 26.8 mmol/L, SaO2 95%) despite 90% FiO2, high PEEP (12 cmH2O) and 
inhaled nitrogen monoxide. Extracorporeal membrane oxygenation (ECMO) was therefore 
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contemplated and the patient transferred to our paediatric intensive care unit where it was 
instituted. 
On his arrival further investigations were performed but there was no evidence of viral (EBV, 
CMV, HSV, enterovirus, metapneumovirus, RSV, influenza A and B, rhinovirus, adenovirus), 
bacterial (negative PCR and serology for Chlamydia pneumoniae and psittaci, negative blood 
cultures), parasitic (Toxoplasma PCR, Toxocara, Bilharzia, Trichinella, Fasciola hepatica 
and Farmers’ lung serology all negative, no amoebae), or fungal infection (Aspergillus 
serology and RAST, Candida PCR all negative). Blood count continued to show a marked 
eosinophilic leukocytosis (white cell count 31x109/L of which 10% eosinophils). A second 
bronchoalveolar lavage showed 180,000 cells/mm3 with 20% eosinophils, 31% macrophages, 
23% lymphocytes and 20% neutrophils and no microorganisms. On the basis of these data a 
diagnosis of idiopathic AEP was made and the patient commenced on methylprednisolone 
4mg/kg/day within 24 hours of the onset of the respiratory symptoms. The hypoxaemia 
improved rapidly (within 24 hours) allowing ECMO weaning after 48 hours and extubation 
on the fifth day. The following day the patient was transferred from intensive care back to the 
paediatric pulmonology unit. Oxygen therapy was discontinued within 24 hours by which 
time the chest X-ray had normalised. Corticosteroid was switched from systemic to oral and 
tailed off over 3 months. The patient was discharged on the 15th day after admission feeling 
well and clinically normal. He remained asymptomatic and clinically normal 3 months after 
discontinuing corticosteroid. 
Discussion 
We here report a particularly severe case of idiopathic AEP which, to the best of our 
knowledge, is the only published case requiring ECMO therapy. 
AEP is a rare disease in childhood.2 Diagnosis is based on an association of characteristic 
features including acute respiratory failure with fever, bilateral infiltrates on the chest X-ray, 
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severe hypoxemia with blood oxygen saturation <90% by pulse oximetry or PaO2 <60 mmHg 
on room air or PaO2/FiO2 ≤ 300 mmHg, “eosinophilic lung” with bronchoalveolar lavage fluid 
leukocytes >25% eosinophils or a predominant eosinophilic infiltrate in lung biopsies in the 
absence of any identifiable aetiology (infection, allergy, toxic exposure to drugs).3 Our case 
illustrates that the initial chest X-ray may suggest the diagnosis, showing diffuse, interstitial 
pulmonary infiltrates and sometimes interstitial oedema with Kerley B lines or pleural 
effusion accompanied by blood hypereosinophilia, although these features are not diagnostic 
in isolation. Histological confirmation of the diagnosis is not necessary when the 
bronchoalveolar lavage fluid shows hypereosinophilia in a context of acute febrile dyspnoea. 
The physiopathology of AEP is not well understood. It appears to result from damage caused 
by eosinophils infiltrating the lung parenchyma and releasing toxic substances such as basic 
proteins, lipid mediators and cytokines. Although the precise mechanisms which induce this 
infiltration in AEP have not yet been fully uncovered, it is sometimes possible to identify 
putative causative agents or trigger factors which initiate the process. Occasionally no such 
agent is apparent, in which case the disease is labelled “idiopathic”.2,4 The plethora of 
presumptive causative agents includes : drugs (antibiotics such as nitrofurantoin, 
clarithromycin, dapsone and minocycline; chemotherapeutic agents such as methotrexate, 
bleomycin and fludarabine; non-steroidal anti-inflammatory drugs; amiodarone; phenytoin; 
captopril); inhalation of dust, smoke or toxins (acetylene, firework smoke, nickel dust, heroin 
and cocaine); respiratory infections such as aspergillosis and coccidioidomycosis. Tobacco is 
frequently cited as a possible co-factor, especially soon (within 3 months) after commencing 
smoking or on resuming smoking after a period of abstinence. In the case of our teenage 
patient, one might hypothesise that his taking up smoking on a background of environmental 
tobacco smoke exposure and possible noxious inhalations while working in a garage may 
have played a part. The fact that he had smoked cannabis just prior to the onset of his 
Page 9 of 21
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
respiratory symptoms also made us wonder whether this might also have been a factor in 
triggering the disease, either through an effect of the cannabis itself or toxins admixed with 
the resin or contaminants such as fungus. In the event we were unable to investigate our 
patient’s cannabis for the presence of such substances. 
Approximately two thirds of patients with AEP require mechanical ventilation because of 
acute respiratory distress, but once the diagnosis is made it can be treated successfully with 
corticosteroid commencing with a high intravenous dosage then switching to oral dosing 
while tailing off.5 The optimal regimen and duration of corticosteroid therapy is uncertain and 
has not been characterised in trials: courses of between 2 and 12 weeks’ duration have been 
reported to be equally effective. The sensitivity of the disease to corticosteroid therapy is 
characteristically spectacular: the clinical, radiological and functional abnormalities, along 
with the alveolar eosinophilia all resolve rapidly. Recurrence is not described. 
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Abstract  
We describe what we believe is an entirely novel case of a 15-year-old boy with idiopathic 
acute eosinophilic pneumonia and unusual, resistant hypoxaemia which necessitated 
extracorporeal membrane oxygenation. Response to corticosteroids was excellent and a full 
recovery was observed. Smoking cigarettes and cannabis on the day the symptoms began may 
have contributed to the occurrence of this rare disease.  
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Introduction  
Acute eosinophilic pneumonia (AEP) is a rare entity with an incidence of 9.1 per 100,000 
person-years which typically affects young men around the age of 30 years.1 We report here 
an extraordinary case of idiopathic AEP in the sense that the patient was young (15 years) and 
the disease extremely severe, requiring mechanical ventilation and extracorporeal membrane 
oxygenation (ECMO) and possibly precipitated or exacerbated by smoking tobacco and 
cannabis. 
Case Report  
A teenaged boy aged 15 was admitted to our paediatric intensive care unit with acute 
respiratory distress syndrome and resistant hypoxaemia requiring ECMO. He had a history of 
atopy and mild asthma which had resolved symptomatically by the time he was 7 years old. 
He was exposed to environmental tobacco smoke regularly at home and for the past few 
months had begun smoking cigarettes occasionally himself. He also reported smoking 
cannabis for the first time about 3 months prior to admission and on a second occasion just a 
few hours before the onset of his current respiratory symptoms. He was in contact at home 
with budgerigars and a dog, and had been working for the past 5 months as a garage 
mechanic. 
24 hours before his admission he had woken up with a fever (38.4°C) accompanied by 
asthenia and odynophagia but no respiratory symptoms. He took some paracetamol. Later on 
in the afternoon, according to his family he smoked cannabis for the second time in 3 months. 
As the evening and night progressed he developed rapidly deteriorating respiratory distress, 
chest tightness and orthopnoea which led him to visit the emergency ward of a nearby 
hospital. On arrival he was noted to be febrile, anxious and hypoxic (pulse oximetry 85% 
saturation on room air). Despite nasal oxygen therapy and ad hoc antibiotic therapy with 
cefotaxime he failed to improve and remained significantly hypoxaemic (pulse oximetry 
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90%) even when administered 20l of oxygen by face mask. He was therefore transferred to 
the intensive care unit. Arterial blood gases showed pH 7.34, PaO2 117 mmHg, PaCO2 42 
mmHg. A chest X-ray showed bilateral alveolar and interstitial infiltrates (Figure 1). Because 
of the progression of the respiratory distress and the appearance of haemodynamic instability, 
he was intubated and commenced on ventilatory support with PaO2/FiO2 ratio 77 mmHg and 
PEEP at 10 cmH2O. Noradrenaline was commenced and anti-infectious therapy widened with 
cefotaxime, levofloxacin, trimethoprim-sulphamethoxazole and amphotericin B. 
Meanwhile other extensive tests were performed. The white cell count was 22 x 109/L with 
0.2 x 109/L eosinophils, C-reactive protein 221 mg/L and procalcitonin 0.87 ng/ml. The 
procalcitonin control was 1.35 ng/ml. The brain natriuretic peptide was 44 pg/ml. 
Nasopharyngeal aspiration did not reveal RSV or A and B influenza viruses. Serology 
(influenza A, B, HIV, Mycoplasma, Chlamydia and Legionella) eventually proved negative. 
Blood cultures remained sterile. Urinary Legionella pneumophila and Streptococcus 
pneumoniae antigens were negative. Complement and immunoglobulin assays were normal. 
There were no signs of immune dysregulation (normal lymphocyte typing, negative 
antinuclear and anticytoplasmic antibodies, negative anti-MPO and anti-PR3 ANA and no 
paraprotein). A CT scan of the thorax confirmed mixed reticular and alveolar bilateral 
pulmonary infiltrates concentrated sub-pleurally with ground-glass opacification and pleural 
effusions consistent with an acute eosinophilic pneumonia (Figure 2). Bronchoalveolar lavage 
returned pinkish fluid with 350 000 cells/mm3 (38% eosinophils, 28% macrophages, 16% 
lymphocytes, 18% neutrophils). There was no evidence of parasitic, fungal, bacterial or viral 
infection. 
The patient developed a refractory hypoxaemia (pH 7.38, PaO2 69.1 mmHg, PaCO2 46.7 
mmHg, HCO3- 26.8 mmol/L, SaO2 95%) despite 90% FiO2, high PEEP (12 cmH2O) and 
inhaled nitrogen monoxide. Extracorporeal membrane oxygenation (ECMO) was therefore 
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contemplated and the patient transferred to our paediatric intensive care unit where it was 
instituted. 
On his arrival further investigations were performed but there was no evidence of viral (EBV, 
CMV, HSV, enterovirus, metapneumovirus, RSV, influenza A and B, rhinovirus, adenovirus), 
bacterial (negative PCR and serology for Chlamydia pneumoniae and psittaci, negative blood 
cultures), parasitic (Toxoplasma PCR, Toxocara, Bilharzia, Trichinella, Fasciola hepatica 
and Farmers’ lung serology all negative, no amoebae), or fungal infection (Aspergillus 
serology and RAST, Candida PCR all negative). Blood count continued to show a marked 
eosinophilic leukocytosis (white cell count 31x109/L of which 10% eosinophils). A second 
bronchoalveolar lavage showed 180,000 cells/mm3 with 20% eosinophils, 31% macrophages, 
23% lymphocytes and 20% neutrophils and no microorganisms. On the basis of these data a 
diagnosis of idiopathic AEP was made and the patient commenced on methylprednisolone 
4mg/kg/day within 24 hours of the onset of the respiratory symptoms. The hypoxaemia 
improved rapidly (within 24 hours) allowing ECMO weaning after 48 hours and extubation 
on the fifth day. The following day the patient was transferred from intensive care back to the 
paediatric pulmonology unit. Oxygen therapy was discontinued within 24 hours by which 
time the chest X-ray had normalised. Corticosteroid was switched from systemic to oral and 
tailed off over 3 months. The patient was discharged on the 15th day after admission feeling 
well and clinically normal. He remained asymptomatic and clinically normal 3 months after 
discontinuing corticosteroid. 
Discussion 
We here report a particularly severe case of idiopathic AEP which, to the best of our 
knowledge, is the only published case requiring ECMO therapy. 
AEP is a rare disease in childhood.2 Diagnosis is based on an association of characteristic 
features including acute respiratory failure with fever, bilateral infiltrates on the chest X-ray, 
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severe hypoxemia with blood oxygen saturation <90% by pulse oximetry or PaO2 <60 mmHg 
on room air or PaO2/FiO2 ≤ 300 mmHg, “eosinophilic lung” with bronchoalveolar lavage fluid 
leukocytes >25% eosinophils or a predominant eosinophilic infiltrate in lung biopsies in the 
absence of any identifiable aetiology (infection, allergy, toxic exposure to drugs).3 Our case 
illustrates that the initial chest X-ray may suggest the diagnosis, showing diffuse, interstitial 
pulmonary infiltrates and sometimes interstitial oedema with Kerley B lines or pleural 
effusion accompanied by blood hypereosinophilia, although these features are not diagnostic 
in isolation. Histological confirmation of the diagnosis is not necessary when the 
bronchoalveolar lavage fluid shows hypereosinophilia in a context of acute febrile dyspnoea. 
The physiopathology of AEP is not well understood. It appears to result from damage caused 
by eosinophils infiltrating the lung parenchyma and releasing toxic substances such as basic 
proteins, lipid mediators and cytokines. Although the precise mechanisms which induce this 
infiltration in AEP have not yet been fully uncovered, it is sometimes possible to identify 
putative causative agents or trigger factors which initiate the process. Occasionally no such 
agent is apparent, in which case the disease is labelled “idiopathic”.2,4 The plethora of 
presumptive causative agents includes : drugs (antibiotics such as nitrofurantoin, 
clarithromycin, dapsone and minocycline; chemotherapeutic agents such as methotrexate, 
bleomycin and fludarabine; non-steroidal anti-inflammatory drugs; amiodarone; phenytoin; 
captopril); inhalation of dust, smoke or toxins (acetylene, firework smoke, nickel dust, heroin 
and cocaine); respiratory infections such as aspergillosis and coccidioidomycosis. Tobacco is 
frequently cited as a possible co-factor, especially soon (within 3 months) after commencing 
smoking or on resuming smoking after a period of abstinence. In the case of our teenage 
patient, one might hypothesise that his taking up smoking on a background of environmental 
tobacco smoke exposure and possible noxious inhalations while working in a garage may 
have played a part. The fact that he had smoked cannabis just prior to the onset of his 
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respiratory symptoms also made us wonder whether this might also have been a factor in 
triggering the disease, either through an effect of the cannabis itself or toxins admixed with 
the resin or contaminants such as fungus. In the event we were unable to investigate our 
patient’s cannabis for the presence of such substances. 
Approximately two thirds of patients with AEP require mechanical ventilation because of 
acute respiratory distress, but once the diagnosis is made it can be treated successfully with 
corticosteroid commencing with a high intravenous dosage then switching to oral dosing 
while tailing off.5 The optimal regimen and duration of corticosteroid therapy is uncertain and 
has not been characterised in trials: courses of between 2 and 12 weeks’ duration have been 
reported to be equally effective. The sensitivity of the disease to corticosteroid therapy is 
characteristically spectacular: the clinical, radiological and functional abnormalities, along 
with the alveolar eosinophilia all resolve rapidly. Recurrence is not described. 
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Figure 1: Chest X-ray showing bilateral alveolar and interstitial infiltrates 
 
 
 
 
Figure 2: CT-scan of the thorax showing bilateral sub-pleural condensations and septal 
thickening in the upper pulmonary lobes (Fig 2A), and diffuse ground-glass opacities, with 
septal thickening in the lower pulmonary lobes, with presence of pleural fluid in the right lobe 
(Fig 2B).  
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Figure 1: Chest X-ray showing bilateral alveolar and interstitial infiltrates 
 
 
 
 
Figure 2: CT-scan of the thorax showing bilateral sub-pleural condensations and septal 
thickening in the upper pulmonary lobes (Fig 2A), and diffuse ground-glass opacities, with 
septal thickening in the lower pulmonary lobes, with presence of pleural fluid in the right lobe 
(Fig 2B).  
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